Cargando…
The endocannabinoid anandamide is an airway relaxant in health and disease
Chronic obstructive airway diseases are a global medical burden that is expected to increase in the near future. However, the underlying mechanistic processes are poorly understood so far. Herein, we show that the endocannabinoid anandamide (AEA) induces prominent airway relaxation in vitro and in v...
Autores principales: | Simon, Annika, von Einem, Thomas, Seidinger, Alexander, Matthey, Michaela, Bindila, Laura, Wenzel, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672354/ https://www.ncbi.nlm.nih.gov/pubmed/36396957 http://dx.doi.org/10.1038/s41467-022-34327-0 |
Ejemplares similares
-
Inhibition of Vascular Growth by Modulation of the Anandamide/Fatty Acid Amide Hydrolase Axis
por: Rieck, Sarah, et al.
Publicado: (2021) -
Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years
por: Maccarrone, Mauro
Publicado: (2017) -
New insights into the mechanisms of anandamide-induced airway dilation placing its degradation enzyme, FAAH center stage. Commentary on: Simon A, von Einem T, Seidinger A, Matthey M, Bindila L, Wenzel D (2022) The endocannabinoid anandamide is an airway relaxant in health and disease. Nat Commun 13:6941
por: Pfitzer, Gabriele
Publicado: (2023) -
The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation
por: Smith, Marie, et al.
Publicado: (2015) -
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2016)